Press Release
Category Added in a WPeMatico Campaign
-
Business Wire1 March 2026
TVCMALL at MWC 2026: Leading Mobile Accessories Wholesale and Smarter Sourcing
BARCELONA, Spain–(BUSINESS WIRE)–As MWC Barcelona 2026 highlights the growing role of AI, connectivity, and smarter technology systems, the mobile accessories…
Read More » -
Business Wire1 March 2026
VZLA Investors Have Opportunity to Join Vizsla Silver Corp. Fraud Investigation with the Schall Law Firm
LOS ANGELES–(BUSINESS WIRE)–$VZLA—The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf…
Read More » -
Business Wire1 March 2026
SEVN Investors Have the Opportunity to Join Investigation of Seven Hills Realty Trust with the Schall Law Firm
LOS ANGELES–(BUSINESS WIRE)–$SEVN—The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf…
Read More » -
Business Wire1 March 2026
KORE Investors Have the Opportunity to Join Investigation of KORE Group Holdings, Inc. with the Schall Law Firm
LOS ANGELES–(BUSINESS WIRE)–$KORE—The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf…
Read More » -
Cision PR Newswire1 March 2026
MWC 2026 Preview | DOOGEE AI Redefines Exploration: A Full-Scenario Ecosystem
BARCELONA, Spain, Feb. 28, 2026 /PRNewswire/ — As MWC 2026 approaches, DOOGEE heads to Barcelona with its new theme: “DOOGEE AI,…
Read More » -
Business Wire28 February 2026
AARD Investors Have Opportunity to Join Aardvark Therapeutics, Inc. Fraud Investigation With the Schall Law Firm
LOS ANGELES–(BUSINESS WIRE)–$AARD—The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf…
Read More » -
MarketersMEDIA Newswire28 February 2026
Flexzo Ai and Island Doctors Announce Multi-Year, Multi-Site Partnership to Deploy AI-Driven Workforce Automation Across Florida
Florida, United States, February 28, 2026 — Flexzo Ai, the AI-powered healthcare workforce platform transforming staffing economics in the United…
Read More » -
Business Wire28 February 2026
KEYTRUDA® (pembrolizumab) Plus WELIREG® (belzutifan) Given as Adjuvant Therapy Reduced the Risk of Disease Recurrence or Death by 28% Compared to KEYTRUDA Monotherapy in Certain Patients With Earlier-Stage Renal Cell Carcinoma (RCC)
This is the first positive Phase 3 trial for WELIREG in earlier-stage disease, the first positive results for a HIF-2α…
Read More » -
Business Wire28 February 2026
WELIREG® (belzutifan) Plus LENVIMA® (lenvatinib) Reduced the Risk of Disease Progression or Death by 30% Compared to Cabozantinib in Certain Previously Treated Patients With Advanced Renal Cell Carcinoma (RCC)
This is the first positive Phase 3 trial of a HIF-2 alpha inhibitor in combination with a multi-targeted tyrosine kinase…
Read More » -
Cision PR Newswire28 February 2026
Well-grounded Confidence! How China’s domestic growth drivers propel a strong start to its 15th Five-Year Plan
BEIJING, Feb. 28, 2026 /PRNewswire/ — A news report from China.org.cn on Chinese economy: The year 2026 marks the beginning…
Read More »

